Odors lead to back order for Pfizer's Levoxyl

Drugs being pulled off of shelves because of bad odors generally have no health risks associated with them, but they cost drugmakers money and consumers inconvenience. Pfizer ($PFE) subsidiary King Pharmaceuticals is recalling 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. The problem was tracked to the oxygen-absorbing canisters in 100-count and 1,000-count bottles but the company decided to pull all of its supplies as a precaution, which landed it on the FDA shortage list. The company said it does not expect to have supplies until 2014. Story | More (PDF)

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.